[Haut Conseil de la Santé Publique (HCSP). Guidance on the prioritization of antiviral drugs in case of seasonal influenza epidemics (March 3, 2015)].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000998:Antiviral Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D002648:Child; D015897:Comorbidity; D019468:Disease Management; D004198:Disease Susceptibility; D004363:Drug Utilization; D058872:Epidemics / Q000517:prevention & control; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D008297:Male; D015201:Meta-Analysis as Topic; D053139:Oseltamivir / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012621:Seasons; D035862:Vulnerable Populations; D053243:Zanamivir / Q000627:therapeutic use
D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir; D053243:Zanamivir